UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (date of earliest event reported): August 9, 2016

                                 AMERICANN, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)

       Delaware                     000-54231                 27-4336843
---------------------------     ------------------          -----------------
(State or other jurisdiction  (Commission File No.)          (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                    ----------------------------------------
          (Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code: (303) 862-9000

                          ---------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications  pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
     Exchange Act (17 CFR 240.13e-4(c))



                                       1
<PAGE>


Item 8.01   Other Events

Agreements with AQUSCAN Delaware Corp.

     On April 12, 2016 AmeriCann  signed  agreements with AQUSCAN Delaware Corp.
("AQUSCAN").  AQUSCAN was one of eleven  applicants for a  vertically-integrated
license to cultivate, process and sell medical cannabis in Delaware.

     AQUSCAN  applied  and was  accepted  as  AmeriCann's  Preferred  Partner in
Delaware  and agreed to become the sole tenant in the planned  Delaware  Medical
Cannabis Center ("DMCC") if a license was awarded. AmeriCann would build and own
the facility.

     The DMCC  project was  designed on 10 acres of  unimproved  land located in
Garrison Oak  Technology  Park in Dover,  DE. The City of Dover,  which owns the
park,  executed  a  Purchase  and  Sale  Agreement  for the  property  that  was
contingent  upon an award of a license.  City officials  were  supportive of the
project and provided letters of support for the AQUSCAN application.

     On August 9th, 2016, AmeriCann received  notification from AQUSCAN that the
Delaware Health and Social  Services,  Division of Public Health,  completed the
evaluation  of  proposals  submitted  to  RFP  #HSS   16-003-Medical   Marijuana
Compassion Center for Kent County and AQUSCAN's proposal was not selected.



                                       2
<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: August 9, 2016
                                      AMERICANN, INC.


                                      By:  /s/ Timothy Keogh
                                          ------------------------------------
                                          Timothy Keogh, Chief Executive Officer




                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8k801aquscan8-16.txt", "description": "8-K 8.01 RE AQUSCAN", "secsgml_size_bytes": 3871}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "161819685"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (date of earliest event reported): August 9, 2016

                                 AMERICANN, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)

       Delaware                     000-54231                 27-4336843
---------------------------     ------------------          -----------------
(State or other jurisdiction  (Commission File No.)          (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                    ----------------------------------------
          (Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code: (303) 862-9000

                          ---------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications  pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
     Exchange Act (17 CFR 240.13e-4(c))

                                       1
Item 8.01   Other Events

Agreements with AQUSCAN Delaware Corp.

     On April 12, 2016 AmeriCann  signed  agreements with AQUSCAN Delaware Corp.
("AQUSCAN").  AQUSCAN was one of eleven  applicants for a  vertically-integrated
license to cultivate, process and sell medical cannabis in Delaware.

     AQUSCAN  applied  and was  accepted  as  AmeriCann's  Preferred  Partner in
Delaware  and agreed to become the sole tenant in the planned  Delaware  Medical
Cannabis Center ("DMCC") if a license was awarded. AmeriCann would build and own
the facility.

     The DMCC  project was  designed on 10 acres of  unimproved  land located in
Garrison Oak  Technology  Park in Dover,  DE. The City of Dover,  which owns the
park,  executed  a  Purchase  and  Sale  Agreement  for the  property  that  was
contingent  upon an award of a license.  City officials  were  supportive of the
project and provided letters of support for the AQUSCAN application.

     On August 9th, 2016, AmeriCann received  notification from AQUSCAN that the
Delaware Health and Social  Services,  Division of Public Health,  completed the
evaluation  of  proposals  submitted  to  RFP  #HSS   16-003-Medical   Marijuana
Compassion Center for Kent County and AQUSCAN's proposal was not selected.

                                       2
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: August 9, 2016
                                      AMERICANN, INC.

                                      By:  /s/ Timothy Keogh
                                          ------------------------------------
                                          Timothy Keogh, Chief Executive Officer

                                       3